Gilead Sciences, Inc’s filing revealed that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.25 million on Dec 29 ’25. In the deal valued at $124.83 per share,10,000 shares were sold. As a result of this transaction, O’Day Daniel Patrick now holds 566,698 shares worth roughly $69.0 million.
Then, DANIEL O’DAY bought 10,000 shares, generating $1,248,272 in total proceeds.
Before that, Dickinson Andrew D sold 3,000 shares. Gilead Sciences, Inc shares valued at $366,000 were divested by the Chief Financial Officer at a price of $122.00 per share. As a result of the transaction, Dickinson Andrew D now holds 153,503 shares, worth roughly $18.69 million.
Scotiabank began covering GILD with “Sector outperform” recommendation on November 13, 2025. Daiwa Securities revised its rating on August 19, 2025. It rated GILD as “an Outperform” which previously was an “a Neutral”.
Price Performance Review of GILD
On Tuesday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock fall -0.69% to $121.76. Over the last five days, the stock has gained 0.33%. Gilead Sciences, Inc shares have risen nearly 35.47% since the year began. Nevertheless, the stocks have fallen -0.80% over the past one year.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2025-12-31, growing by 4.67 million shares to a total of 23.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 18.48 million shares. There was a rise of 20.19%, which implies that there is a positive sentiment for the stock.
